EGM
CATX icon

Engineers Gate Manager’s Perspective Therapeutics CATX Stock Holding History

Engineers Gate Manager’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-12,562
Closed -$34.5K – 2212
2025
Q4 		$34.5K Buy
+12,562
New +$35.8K ﹤0.01% 2001
2025
Q3 		– Sell
-28,708
Closed -$98.8K – 2202
2025
Q2 		$98.8K Sell
28,708
-90,240
-76% -$238K ﹤0.01% 1998
2025
Q1 		$253K Sell
118,948
-11,652
-9% -$35K ﹤0.01% 1791
2024
Q4 		$417K Buy
+130,600
New +$1.07M 0.01% 1545
2021
Q2 		– Sell
-1,190
Closed -$13K – 1645
2021
Q1 		$13K Buy
+1,190
New +$18K ﹤0.01% 1768

Other funds holding CATX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Engineers Gate Manager's CATX Position: Q1 2026 in Review

Engineers Gate Manager sold out of Perspective Therapeutics (CATX) in Q1 2026, closing a stake of 12,562 shares — an estimated $34.5K sold.

Engineers Gate Manager first reported a position in CATX in Q1 2021 and held it in 5 quarters. The position peaked at $417K in Q4 2024. 138 funds tracked by Wall St. Rank hold CATX as of Q1 2026.

  • Engineers Gate Manager reported no remaining Perspective Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 12,562 Perspective Therapeutics shares in Q1 2026, an estimated $34.5K.
  • Engineers Gate Manager first reported a position in Perspective Therapeutics in Q1 2021 and held it in 5 quarters.
  • Engineers Gate Manager's Perspective Therapeutics position peaked at $417K in Q4 2024.
  • 138 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.